Glucose Monitoring Firm DexCom Files IPO A Month After Raising Series D

DexCom Inc., a development-stage medical device company focused on glucose
monitoring systems for people with diabetes, filed an initial public offering to
sell up to $70 million in common stock, according to registration materials the
firm submitted Tuesday to the Securities and Exchange Commission.